Arrowhead Research | ARWR - Interest Income


Arrowhead Research reported $9.05M in Interest Income for its fiscal quarter ending in September of 2025.





Interest Income Change Date
Agios Pharmaceuticals USD 13.37M 1.14M Sep/2025
Alnylam Pharmaceuticals USD 28.68M 1.19M Sep/2025
Arrowhead Research USD 9.05M 1.97M Sep/2025
Heron Therapeutics USD 433K 277K Dec/2021
Incyte USD 30.75M 3.97M Dec/2025
Ionis Pharmaceuticals USD -0.66 0.29 Dec/2024
Ligand Pharmaceuticals USD 3.87M 2.25M Sep/2025
Merck USD 96M 27M Sep/2025
Moderna USD 73M 8M Sep/2025
Nektar Therapeutics USD -0.18 0.07 Sep/2024
Sarepta Therapeutics USD 8.38M 1.24M Sep/2025
Ultragenyx Pharmaceutical USD 5.86M 69K Sep/2025
Vertex Pharmaceuticals USD 125.7M 3.3M Sep/2025
Xencor USD 6.54M 710K Sep/2025